Randox’s arrays offer simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling.

Company announced the CE marking of MycAssay™ Aspergillus and MycAssay™ Pneumocystis on the Roche Lightcycler® 2.0 and Stratagene Mx3000 series platforms.

Company announces the market reintroduction of Optison™ for use in select echocardiograms.

Roche LightCycler utilized for rapid methylation detection in archival tissue samples.

Launches new PCR Arrays for gene expression profiling in nephrotoxicity, hepatotoxicology, differentiation and embryonic stem cells markers.

Print quality improvements and walk-away automation is expected to increase research productivity and lower operating costs.

Newly developed microarray contains millions of newly discovered genome-wide common and rare variants from the 1,000 Genomes Project.

New reusable integrated IFCs will lower SNP genotyping costs and are designed to support accelerated sample throughput.

AMSBIO announces a new second generation PARP in vivo Pharmacodynamic Assay to measure net poly (ADP-ribose) (PAR) levels in cellular extracts.

Ingen Biosciences’ kit, BJI InoPlex™, detects in the range of 75 per cent of infections found in joint replacements.